Intelligent Bio Solutions (INBS) Income from Continuing Operations (2019 - 2025)
Intelligent Bio Solutions (INBS) recorded quarterly Income from Continuing Operations of 2550561.0 in Q1 2025, down 13.05% quarter-over-quarter from 2256047.0 in Q4 2024, and up 14.58% on a YoY basis from 2226085.11 in Q1 2024.
Intelligent Bio Solutions (INBS) Income from Continuing Operations (2019 - 2025) Analysis & Trends
Intelligent Bio Solutions' Income from Continuing Operations history runs 7 years deep, the most recent figure standing at 2550561.0 for Q1 2025.
- In Q1 2025, Income from Continuing Operations rose 14.58% year-over-year to 2550561.0; the TTM figure through Mar 2025 stood at 10313073.0 (changed 0.4% YoY), while the FY2024 annual figure was 10283174.0, up 18.29% from the prior year.
- Income from Continuing Operations was 2550561.0 for Q1 2025 at Intelligent Bio Solutions, down from 2256047.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 850230.0 in Q2 2021 to a low of 6352017.0 in Q1 2023.
- Historically, Income from Continuing Operations has averaged 2505932.24 across 5 years, with a median of 2550561.0 in 2025.
- The sharpest annual moves came in 2021 and 2022: Income from Continuing Operations sank 2728.5% in 2021, then surged 57.23% in 2022.
- A 5-year view of Income from Continuing Operations shows it stood at 3463823.0 in 2021, then jumped by 38.52% to 2129494.0 in 2022, then gained by 5.13% to 2020316.0 in 2023, then decreased by 11.67% to 2256047.0 in 2024, then fell by 13.05% to 2550561.0 in 2025.
- The last three Income from Continuing Operations figures came in at 2550561.0 (Q1 2025), 2256047.0 (Q4 2024), and 2694748.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Intelligent Bio Solutions | 12.67 Mn | 11.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -2.55 Mn |
| Dec 31, 2024 | -2.26 Mn |
| Sep 30, 2024 | -2.69 Mn |
| Jun 30, 2024 | -2.81 Mn |
| Mar 31, 2024 | -2.99 Mn |
| Dec 31, 2023 | -2.02 Mn |
| Sep 30, 2023 | -2.56 Mn |
| Jun 30, 2023 | -2.70 Mn |
| Mar 31, 2023 | -6.35 Mn |
| Dec 31, 2022 | -2.13 Mn |
| Sep 30, 2022 | -1.21 Mn |
| Jun 30, 2022 | -2.08 Mn |
| Mar 31, 2022 | -1.34 Mn |
| Dec 31, 2021 | -3.46 Mn |
| Sep 30, 2021 | -1.44 Mn |
| Jun 30, 2021 | -850,230.00 |
| Mar 31, 2021 | -3.14 Mn |
| Dec 31, 2020 | -1.99 Mn |
| Sep 30, 2020 | -1.08 Mn |
| Jun 30, 2020 | -463,980.00 |